CRBU
Caribou Biosciences Inc
NASDAQ: CRBU · HEALTHCARE · BIOTECHNOLOGY
$1.88
-2.08% today
Updated 2026-04-30
Market cap
$205.84M
P/E ratio
—
P/S ratio
18.45x
EPS (TTM)
$-1.59
Dividend yield
—
52W range
$1 – $4
Volume
1.4M
Caribou Biosciences Inc (CRBU) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $61.93M | $36.05M | $442.36M | $373.76M | $432.21M | $313.31M |
| Cash & equivalents | $41.07M | $15.95M | $240.42M | $58.34M | $51.16M | $16.29M |
| Current assets | $57.01M | $24.31M | $391.19M | $260.25M | $338.84M | $219.38M |
| Total liabilities | $54.47M | $59.48M | $54.53M | $72.89M | $63.81M | $60.36M |
| Current liabilities | $10.08M | $12.39M | $25.83M | $28.13M | $28.30M | $30.65M |
| Long-term debt | — | $924000.00 | — | — | — | — |
| Shareholder equity | $7.46M | $-23.44M | $387.82M | $300.87M | $368.40M | $252.95M |
| Retained earnings | $3.44M | $-30.87M | $-97.79M | $-197.22M | $-299.29M | $-448.39M |
| Accounts receivable | $3.98M | $5.16M | $8.12M | $4.66M | $3.86M | $3.25M |
| Inventory | $3.18M | $2.43M | $-31.11M | $-62.57M | — | — |
| Goodwill | — | — | — | — | — | — |